INTRODUCTION
The presence of blood borne infections in blood cells or plasma of asymptomatic donors is the major risk factors for transmitting infectious agents through blood transfusion. Although blood transfusion service is mandatory to save the life of many patients who suffer from the loss of blood, it is an ideal vehicle for transmission of any infectious organism that may present in the blood (1) . Common infectious agents include hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV) and syphilis (2, 3) .
Unsafe blood transfusion is very costly from both human and economic points of view. Transfusion transmissible infectious diseases carry long term consequences for the recipients, families and the communities since the infected person represents a pool for the infection and can transmit the disease during its asymptomatic period. Therefore, transfusions can contribute to an ever widening pool of infection in the population (4, 5) .
In developing countries, blood safety continues to be a major problem due to the high prevalence of infectious markers among blood donors (5) . In sub-Saharan African countries, factors contributing to transfusion-related transmissions include a high prevalence of HIV and other transfusion transmitted infections in the general and blood donor populations; inadequate screening facilities; and lack of infrastructure and capacity to ensure sustainable operations (2) . Sexually transmitted infections are also widespread in developing countries and constitute a major public health problem (6, 7) . Syphilis has acquired a new potential for morbidity and mortality through association with increased risk of HIV infection, thus making more difficult to get safe blood (8) . Ethiopia, being part of developing countries, has a high prevalence of HIV, HBV and other infectious diseases (9) .
The prevalence of transfusion transmissible infections (TTIs) can reveal the problem of unnoticeable infections in healthy-looking members of the general population and also provide data that is important in formulating the strategies for improving the management of a safe blood supply. Although there are available data on the prevalence of these diseases in a general population and its high-risk population has been addressed (10) (11) (12) , there are limited epidemiological data on TTIs on blood donors in Ethiopia (13, 14) , especially in the eastern areas of Ethiopia. Therefore, this study was conducted to determine the prevalence and trends of major TTIs among blood donors at Dire Dawa Blood Bank in Eastern Ethiopia.
MATERIALS AND METHODS
We conducted a retrospective analysis of blood donor data recorded between December 2011 and May 2012 at Dire Dawa blood bank which is located 515 Km East from the capital city, Addis Ababa. Dire Dawa blood bank is a regional blood bank established in 1988. According to the 2007 population census conducted by the Central Statistical Agency of Ethiopia (CSA), Dire Dawa had an estimated total population of 341,834 (15) . There are four hospitals (one governmental and three private) and 15 health centers in the administration. The blood bank collects blood centrally and distributes blood for transfusion medicine to Dilchora hospital, the hospital serving as a referral hospital in the administration, and to other general hospitals and health institutions found in Dire Dawa administration.
The study population consisted of apparently healthy voluntary and replacement donors who presented for blood donation at the blood bank in the past three years. Voluntary donors are motivated blood donors who donate blood at regular intervals while replacement donors are usually one time blood donors who donate blood only when a relative or a friend is in need of blood.
During the first step of the screening process, individuals are required to give answers to a panel of questions about previous illnesses and medical conditions. Apparently healthy subjects of age 18 to 65 years with body weight above 45 kg would qualify for donation. The socio-demographic histories of the donors were recorded in the logbook, and venous blood was collected. All blood donors with complete records of their socio-demographic and clinical data were included in the study. Donors with incomplete record were excluded from the study. Donor's blood was screened for TTIs after donation. The blood samples were tested for anti-HIV, HBsAg and anti-HCV, and anti-syphilis antibody with standard enzyme-linked immunosorbent assay (ELISA) test kits. The hepatitis B surface antigen (HBsAg) was detected using Hepanostika HBsAg Ultra (Biomérieux, Boxtel, Netherlands), and the kit had a sensitivity of 100% and specificity of 99.9%. Antibodies to HCV were detected using Hepanostika HCV Ultra (Beijing United Biomedical Co. Ltd., Beijing, China) which had a sensitivity of 100% and specificity of 99.7%. Antibodies to HIV types 1 and 2 were screened using Vironostika HIV UniForm II Ag/Ab (Biomérieux, Boxtel, Netherlands). The kit had a sensitivity of 100 % and specificity of 99.7%. Antibody for treponema pallidum was tested using rapid plasma reagin test (RPR, Wampole Laboratories, Princeton, N.J., USA) which had a sensitivity of 100%.
All data were entered into Microsoft Excel spreadsheets and analyzed using STATA software version 13 (STATA Corp. College Station, Texas, USA). The seroprevalence of HIV, HCV, HBsAg and syphilis was expressed in percentages for the entire study group and by age, sex and donor category and comparisons between the groups were done using Pearson Chi-Square. Logistic regression was used to determine the associations between the occurrence of TTIs and selected variables. The associations are presented as odds ratio (OR) together with 95% confidence intervals (CI). P-value less than 0.05 was considered statistically significant.
The study proposal was approved by the Institutional Research and Ethics Review Committee of the College of Health and Medical Sciences, Haramaya University. With regard to confidentiality, no names were involved in the data analysis process; only codes were used to identify donors.
RESULTS

Characteristics of the blood donors:
A total of 6376 blood donors were screened at Dire Dawa Blood Bank Unit from July 2010 to June 2013. Among them, 5430(85.16%) were males. The median age of the study subjects was 27 (ranging from 18 -65), and 2437(38.22 %) were in the age group of 18-24 years old. Then, 5647(88.57%) were replacement donor while 729(11.43%) were volunteers. Of all donors, 3184(49.94%) were blood group O and 6128(96.11%) were Rhesus positive. The majority of the blood donors were students, 1781(27.93%), followed by private workers, 1439(22.57%). Of the volunteer donors, 408(55.97%) were students, and there were 1,373(24.31%) students for replacement donors. (Table  1) . 
Transfusion-transmissible infection (TTI) positivity rate by demographic characteristics:
The prevalence of TTIs was significantly higher for male donors (7.46%) than for female donors (4.76%) (P=0.003). HBV infections were significantly more prevalent among males than female donors (P<0.001). Similarly, HCV, HIV and syphilis infections were more prevalent among the males, but none of the differences were significant (P>0.05). The prevalence of TTIs increased with age. Donors with age group 18-24 (5.87%) showed a low prevalence of TTI. Similarly, HIV infection was less prevalent among donors with age group 18-24(0.57%) ( Table 2 ). The TTIs prevalence also showed significant differences among different types of occupation (P=0.010). Unemployed donors showed the highest prevalence (9.63%) of TTIs followed by private workers (7.51%) and drivers (7.48%). The prevalence of TTIs was 7.26% for replacement and 5.49% for volunteer donors, without significant difference (P>0.05). Among the four TTIs, HIV infection was more prevalent in replacement donors (1.36%) than in volunteer donors (0.27%) (P=0.012) ( Table 2 ).
Multivariate analysis showed that, over all, the prevalence of TTIs was significantly higher among male blood donors (p=0.003) compared to female donors. It was significantly higher among the age group 25-32 years (p=0.013) and 33-40 years (p=0.013) compared to age group 18-24 years old. It was also significantly higher among unemployed (P=0.034) and private workers (p=0.004) compared to students (Table 3) . (20, 21) and Africa (18, 22) . Among the volunteer donors in this study, students comprise the greatest proportion (55.97%). This indicates that students participate more frequently in volunteer donation campaigns.
Presence of low proportion of voluntary blood donors in this study probably reflects a basic lack of awareness and health education in the general population. The other reasons might be the presence of misconceptions and fears associated with donating blood. Special programs must be organized to expand volunteer donation in order to provide a safe blood to meet clinical demand. Therefore, much work remains to be undertaken to develop the highest level in motivating and recruiting volunteers, nonremunerated donors; creating awareness, and standardization of the quality of service in the region.
The male predominance in blood donation in this study may be explained by the fact that there is a general belief that men are healthier than women, and thus are more suitable for blood donation (23, 24) . It can be also explained in part by some physiological status of women like menstruation, pregnancy and breast feeding, which prohibited the females from the blood donation temporarily (19) .
In this study, the age groups of 18 to 24 years and 25 to 32 years were the most represented with percentages of 38.22% and 32.23% respectively. This indicates that the youth are the main blood donors. This might be explained by the fact that Ethiopia as one of the developing countries, the young represent the biggest fraction of the population compared to the older age (25) and that they are also the major age groups that fulfill the selection criteria for blood donation compared to the other age groups (older age).
This study showed that 7.06% of the donated blood was seropositive for at least one of the screened markers. This magnitude is low compared to the finding of a similar study conducted in Gonder, Northwest Ethiopia, which reported a prevalence of 9.5% transfusion transmissible infections among blood donors (14) . Another cross-sectional study reported from Felege Hiwot Referral Hospital, Northwest Ethiopia reported a very high prevalence (43.2%) of blood borne infections among blood donors compared to our study (13) . When compared to other studies conducted in other African countries, the prevalence of TTI in this study is high compared to Namibia, 1.3%, (26) and low compared to Tanzania, 15.9% (18) .
In this study, the overall positivity rates of HBV, HIV, HCV and syphilis were 4.67%, 1.24%, 0.96% and 0.44% respectively. The seroprevalence of HBV (4.67%) in this study is in agreement with a previous finding from Western Ethiopia (Gonder) (4.7%) (14) and lower than 25% in Ethiopia (13), 10.53% in Ghana (16), 7.5% in Nigeria (27), 10.1% and 6.76% in Cameroon (17) and 8.8% in Tanzania (18) . However, it is higher than the 0.46% in Nepal (28), 0.87% in China (29), 1.93% in India (30), 3.91% in Pakistan (31) and 0.6% in Namibia (26) .
The overall prevalence of HIV (1.24%) in this study is lower than the 3.8%, 5.9% and 13.3% in Ethiopia (13, 14, 32) . Similarly, it is lower than the 3% in Sudan (33), 4.1% in Cameroon (17), 3.09% in Gabonese (22) and 3.8% in Tanzania (18) . However, it is higher than the findings from Nepal (0.12%) (28) , China (0.86%) (29) , India (0.14%) (34) , Namibia (0.3%) (26) and Nigeria (0.96%) (27) .
The prevalence rate of HCV infection in blood donors was revealed to be 0.96%, which is lower than 5.63% in Ghana (16) (18) . However, it is higher compared to 0.7% in Ethiopia (14) , 0.64% in Nepal (28), 0.31% in China (29) , 0.27% in India (30) and 0.1% in Namibia (26) .
The 0.44% of syphilis positive donations among donors in this study was low compared to other study findings done in other African countries, 1.3%, in Western Ethiopia (14), 2.61%, in Nigeria (27), 2.7%, in Sudan (33), 4.7% in Tanzania (18) , and 5.7% in Cameroon (17) . However, the prevalence was higher compared to different findings from India (0.16%) (30) .
A comparison of our result with other studies from different countries showed a variable result. This might be explained by the difference in epidemiology and transmission of TTIs in different parts of the world. Other potential factors that might contribute to the variable pattern of TTIs can be difference in population in terms of lifestyle, awareness, sensitivity, specificity of tests and donor selection criteria.
In this study, overall trend analysis for TTIs showed a significant decrease from 9.51% to 6.95% among blood donors over the study period. This trend is similar with the findings of studies conducted in Northwest Ethiopia (14) . The declining trends of the seroprevalence of TTIs may be due to the changes/improvements made by the blood bank for proper selection of donors. Separately, each pathogen shows different trends. The trend for HBV shows a continuous decrease from 2010 to 2012 year, but slight increase in 2013. The trend for prevalence of syphilis decreased progressively over the study period. This finding is consistent with the observed declining trend of syphilis infections among blood donors in Gonder (14) and declining trend of syphilis infections among pregnant women in Addis Ababa (12) . Similar declining trend of syphilis was reported from Bhopa (35) , Nigeria (27) and Dhiraj (Piparia) (36) . This decrease may be related to a positive effect of the prevention programs against HIV, as syphilis is a sexually transmitted disease.
The prevalence of TTIs was significantly higher among male donors (7.46%) compared to female donors (4.76%). The difference is significant for HBV infections, but not significant for HCV, HIV and syphilis infections. This might be due to some risk behaviors such as outside socialization, multiple sex relationships which frequently observed in Males. It may also be due to fewer females donating blood; hence, fewer females are screened compared to males.
Seroprevalence rates of TTIs in relation to age range distribution showed that the prevalence of TTIs increased with age. Donors with age group 18-24 (6.20%) showed a low prevalence of TTIs. The difference is significant for HIV, in which less prevalence is observed among donors with age group 18-24(0.60%). For HBV, HCV and syphilis infection, the prevalence rate was lowest in the same age range though it is not significant. This is in contrary to the fact that the life period of 15 to 25 years is also a period of intense sexual activity favorable to the infection transmission. This might be due to a success on the part of government agencies and nongovernmental organizations in the fight against new HIV infections in this age group.
It is known that malaria is endemic in Ethiopia (37) . However, most of the blood banks in Ethiopia do not screen blood donors for malaria. Similarly, blood donors were not screened for malaria at the Dire Dawa blood bank during the time of the study. They screened malaria only by assessing the donors for the past history of malaria infection. Therefore, testing donors for malaria should be initiated and promoted on the site for the development of transfusion services.
This study had some limitations. It collected information from secondary data which cannot be assessed for different factors that are epidemiologically important. A single positive test was considered positive for the purpose of this study. There was no confirmatory test performed. Therefore, false positives cannot be excluded, and that the true infectious disease rates may be lower than the reported.
In conclusion, this study has shown that a significant percentage of the blood donors harbor TTIs. Although the prevalence of TTIs in the study area shows a decreasing trend, the observed prevalence at each year are still high. The decreasing trends of sero-prevalence of HBV, HCV, HIV and syphilis prevalence in blood donors did not mean safe blood supply. Hence, stringent donor selection, strict pre-screening using standard methods, subsequent follow-up for TTIs after blood transfusion and preventive measures to control infections in the general population are highly recommended to ensure the safety of blood for recipient.
Blood safety remains an issue of major concern in this study area where replacement donors are predominant. Efforts on motivating, educating and creating awareness in the community should be made to increase the proportions of voluntary donors.
